Skip to search formSkip to main contentSkip to account menu

quinacainol

Known as: 1-(4-(2-tert-butylquinolyl))-3-(4-piperidyl)propanol, 4-Quinolinemethanol, 2-(1,1-dimethylethyl)-alpha-(2-(4-piperidinyl)ethyl)- 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

PK 10139

Broader (1)

Quinolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
BLOCK OF Na+ AND K+ CURRENTS IN RAT VENTRICULAR MYOCYTES BY QUINACAINOL AND QUINIDINE
1. The electrophysiological actions of quinacainol were investigated on sodium (INa), transient outward (ito) and sustained… 
1992
1992
A new ECG measure (RSh) for detecting possible sodium channel blockade in vivo in rats.
1992
1992
Quinacainol, a new antiarrhythmic with class I antiarrhythmic actions in the rat.
1991
1991
Haemodynamic effects of intravenous quinacainol with and without autonomic nervous system blockade.
1990
1990
Electrical stimulation studies with quinacainol, a putative 1C agent, in the anaesthetised rat.
1990
1990
Electrical stimulation studies with quinacainol, a putative 1C agent, in the anaesthetised rat.
1990
1990
[Hemodynamic effects of quinacainol administered via an intravenous route. Study in patients with normal left ventricular function].
The haemodynamic effects of a new antiarrhythmic drug quinacainol (RP 54272) were evaluated in 12 untreated patients with normal… 
1990
1990
Pharmacological and antiarrhythmic properties of quinacainol : a new sodium channel blocker?
1990
1990
Hemodynamic effects of intravenously administered quinacainol evaluation in patients with normal left ventricular function
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)